We are live on
!
Find out more
PBPIA
Pivotal bioVenture Partners Investment Advisor Portfolio holdings
AUM
$280M
1-Year Est. Return
181.4%
This Fund
S&P 500
1 Year Est. Return
+181.4%
AUM
$280M
AUM Growth
+$21.1M
(+8.2%)
Holding
13
Top Sells
| 1 | +$16.1M | |
| 2 | +$274K | |
| 3 | +$271K | |
| 4 |
Rallybio
RLYB
|
+$14 |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Vaxcyte
PCVX
$6.69B
| $79.8M | 28.51% |
1,372,425
|
|
||
2
Oculis Holding
OCS
$647M
| $44.7M | 15.97% |
1,680,283
-608,375
|
|
||
|
EVMN
3
Evommune Inc
EVMN
$727M
| $44.3M | 15.83% |
1,926,943
|
|
||
4
Arcutis Biotherapeutics
ARQT
$2.69B
| $31.9M | 11.42% |
1,355,892
-10,732
|
|
||
5
Trevi Therapeutics
TRVI
$1.92B
| $18.5M | 6.63% |
1,553,726
+296,944
|
|
||
6
Immunome
IMNM
$2.11B
| $16M | 5.73% |
732,512
|
|
||
|
MPLT
7
MapLight Therapeutics
MPLT
$1.34B
| $12.4M | 4.44% |
611,447
|
|
||
|
ZBIO
8
Zenas BioPharma
ZBIO
$1.11B
| $11.6M | 4.14% |
591,991
|
|
||
|
BIOA
9
BioAge Labs
BIOA
$689M
| $11.4M | 4.08% |
653,374
|
|
||
10
Avalo Therapeutics
AVTX
$670M
| $4.42M | 1.58% |
+295,933
|
|
||
|
11
Rallybio
RLYB
$92.3M
| $2.7M | 0.96% |
300,579
-2
|
|
||
12
Recursion Pharmaceuticals
RXRX
$1.76B
| $1.83M | 0.65% |
595,518
|
|
||
13
Bolt Biotherapeutics
BOLT
$9.07M
| $172K | 0.06% |
42,581
-51,992
|
|